Table 3.
Treatment | Tissue/Organ | Log CFU Gram tissue (n=3) | Percentage of survival 15 day after the therapy (n=10) |
---|---|---|---|
Lung | 4.312±0.5 | ||
Liver | 4.801±0.4 | ||
Control without drug administration | Kidney | 4.923±1.1 | None survived |
(received physiological saline) | Spleen | 4.742±1.3 | |
Brain | 4.221±1.6 | ||
Lung | 4.310±0.3 | ||
Liver | 4.843±0.7 | ||
Empty nanospheres | Kidney | 4.901±0.8 | None survived |
(1 mg Kg−1, I.V.) | Spleen | 4.698±0.9 | |
Brain | 4.250±1.1 | ||
Lung | 4.017±0.03 | ||
Free AmB | Liver | 4.216±0.13 | |
(1 mg Kg−1, I.V.) | Kidney | 4.736±0.19 | 20 |
Spleen | 4.380±1.1 | ||
Brain | 3.510±0.20 | ||
Lung | 1.193±0.04 * | ||
AmB-loaded nanospheres | Liver | 1.189±0.03 * | |
(1 mg Kg−1, I.V.) | Kidney | Nil ** | 90 |
Spleen | Nil ** | ||
Brain | 1.116±0.03 * |
The values are expressed as mean±S.E.M. from three separate experiments. Analysis of variance of one-way classification between the treatment means was heterogeneous and the t-test values (two-tailed) were significant
p < 0.05
p < 0.001